low grade gliomas
Showing 1 - 25 of >10,000
Brain Tumors Trial in San Diego, Atlanta (Poly ICLC)
Completed
- Brain Tumors
- Poly ICLC
-
San Diego, California
- +1 more
Apr 20, 2022
Intraoperative Hyperspectral Imaging for Fluorescence Guided
Not yet recruiting
- Neurosurgery
- +2 more
-
London, United KingdomKing's College NHS Foundation Trust
Aug 16, 2022
Pediatric Recurrent Progressive Low-grade Gliomas, Pediatric Progressive Low-grade Gliomas Trial in United States (Everolimus)
Active, not recruiting
- Pediatric Recurrent Progressive Low-grade Gliomas
- Pediatric Progressive Low-grade Gliomas
-
Los Angeles, California
- +17 more
Jun 27, 2022
Low-grade Glioma, Pediatric Brain Tumor Trial in Beijing (combined therapy with rh-ES and CV)
Recruiting
- Low-grade Glioma
- Pediatric Brain Tumor
- combined therapy with rh-ES and CV
-
Beijing, ChinaCapital Medical University Sanbo Brain Hospital
Feb 10, 2022
Glioma, Low-grade Glioma, Low Grade Glioma of Brain Trial in Philadelphia (18F-Fluciclovine)
Not yet recruiting
- Glioma
- +4 more
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Oct 3, 2022
NF1, Low-grade Glioma Trial in United States (Poly ICLC)
Recruiting
- NF1
- Low-grade Glioma
- Poly ICLC
-
Birmingham, Alabama
- +18 more
Jan 5, 2023
Low-grade Glioma Trial in San Francisco (ReMind iPad app, Healthy SMS texting, In-person cognitive rehabilitation)
Recruiting
- Low-grade Glioma
- ReMind iPad app
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 16, 2022
Frameshift Peptides of Children With NF1
Completed
- Neurofibromatosis Type 1
- Frameshift Array blood sample test
-
Washington, District of Columbia
- +2 more
Aug 29, 2022
Low Grade Glioma Trial in Pittsburgh (Experimental: HLA-A2 Restricted Glioma Antigen-Peptides with Poly-ICLC)
Recruiting
- Low Grade Glioma
- Experimental: HLA-A2 Restricted Glioma Antigen-Peptides with Poly-ICLC
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
Aug 3, 2021
Low Grade Glioma of Brain Trial in Durham (PEPIDH1M vaccine + vorasidenib)
Not yet recruiting
- Low Grade Glioma of Brain
- PEPIDH1M vaccine + vorasidenib
-
Durham, North CarolinaDuke University Medical Center
Nov 2, 2022
Glioma, Gliomas, High Grade Glioma Trial run by the National Cancer Institute (NCI) (3T MRI scanner)
Recruiting
- Glioma
- +4 more
- 3T MRI scanner
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Recurrent World Health Organization (WHO) Grade II Glioma Trial in United States (Everolimus, Trametinib)
Recruiting
- Recurrent World Health Organization (WHO) Grade II Glioma
-
Birmingham, Alabama
- +11 more
May 6, 2022
Glioma, Glioma Intracranial, Gliomas Benign Trial (RNS System Implantation)
Not yet recruiting
- Glioma
- +5 more
- RNS System Implantation
- (no location specified)
Nov 10, 2021
MR Textural Analysis in Low Grade Gliomas
Completed
- Glioma
-
Nice, FranceNice University Hospital
Feb 15, 2021
Glioma Trial in Boston (Supplemental High Fat Low Carbohydrate (sHFLC) + KetoPhyt)
Not yet recruiting
- Glioma
- Supplemental High Fat Low Carbohydrate (sHFLC) + KetoPhyt
-
Boston, MassachusettsTufts Medical Center
Dec 8, 2022
Low-grade Glioma, IDH2 Gene Mutation, Recurrent Glioma Trial in Boston (Niraparib, Resection/Treatment with Niraparib)
Recruiting
- Low-grade Glioma
- +4 more
- Niraparib
- Resection/Treatment with Niraparib
-
Boston, MassachusettsMassachusetts General Hospital
Oct 19, 2022
Advanced Solid Tumor, CNS Tumor, Recurrent WHO Grade II Glioma Trial in Canada, Germany, United States (Infigratinib)
Not yet recruiting
- Advanced Solid Tumor
- +2 more
-
Palo Alto, California
- +9 more
Aug 2, 2022
Glioma Trial in Ulm (no interventions)
Recruiting
- Glioma
- no interventions
-
Ulm, GermanyUniversity of Ulm
Nov 3, 2020
Adult Brain Tumor, Adult Brain Stem Glioma, Adult Diffuse Astrocytoma Trial in Philadelphia (radiation, procedure, other)
Completed
- Adult Brain Tumor
- +11 more
- proton beam radiation therapy
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Dec 8, 2020
Foci of Tumor Heterogeneity in Diffuse Low-Grade Gliomas
Completed
- Glioma
-
Montpellier, FranceUh Montpellier
Jun 4, 2020